150 related articles for article (PubMed ID: 3058859)
1. Extreme insulin resistance: a consequence of insulin switching?
Keenan WF; Abgott MA
J Fam Pract; 1988 Dec; 27(6):635-6. PubMed ID: 3058859
[No Abstract] [Full Text] [Related]
2. [Insulin and immunology--a correlation].
Federlin K; Velcóvsky HG; Becker F; Discher T; Hammes HP; Marhoffer W
Z Gesamte Inn Med; 1990 Oct; 45(20):601-4. PubMed ID: 2099577
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of type I diabetes mellitus with biosynthetic human insulin].
Guagnano MT; Anichini M; Della Loggia F; Renzetti A; Vitacolonna E; Sensi S
Boll Soc Ital Biol Sper; 1985 Sep; 61(9):1267-72. PubMed ID: 3907668
[No Abstract] [Full Text] [Related]
4. [Insulin antibodies and the actual insulin requirements in children and adolescents with primary diabetes].
Karczewska K; Feluś E; Panek G; Otto-Buczkowska E; Dudziak Z
Med Dosw Mikrobiol; 1974; 26(4):325-30. PubMed ID: 4475336
[No Abstract] [Full Text] [Related]
5. [Antibodies against therapeutic animal insulins and homologous proteins in the course of diabetes in children and adolescents].
Karczewska K
Med Dosw Mikrobiol; 1974; 26(4):317-24. PubMed ID: 4475335
[No Abstract] [Full Text] [Related]
6. Subcutaneous insulin resistance syndrome. Effects of long-term aprotinin therapy.
Guillausseau PJ; Guillausseau C; Boucheteil P; Lubetzki J
Diabetes Res; 1986 Sep; 3(7):387-9. PubMed ID: 2430751
[TBL] [Abstract][Full Text] [Related]
7. Insulin binding to erythrocytes in insulin dependent diabetics with different insulin requirement and insulin antibody titre.
Turco GL; Bruni B; Brossa C; D'Alberto M; Grassi G; Gamba Ansaldi S; Censon A
J Nucl Med Allied Sci; 1984; 28(3):149-55. PubMed ID: 6397582
[No Abstract] [Full Text] [Related]
8. [Insulin resistance due to antibody in type I diabetes].
Enríquez Acosta L
Rev Clin Esp; 1984 Jan; 172(1):57-8. PubMed ID: 6369446
[No Abstract] [Full Text] [Related]
9. [Insulin treatment of type I diabetes--a review].
Arnqvist H
Lakartidningen; 1986 Jun; 83(25):2311-4. PubMed ID: 3526055
[No Abstract] [Full Text] [Related]
10. Insulin--binding antibodies in Nigerian diabetic patients.
Bella AF; Adetuyibi A
West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin].
Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A
Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230
[No Abstract] [Full Text] [Related]
12. Immunogenicity of semisynthetic human insulin.
Rogala H; Lawecki J; Czyzyk A
Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
[No Abstract] [Full Text] [Related]
13. [Avidity and binding capacity of bovine and porcine insulin binding antibodies in childhood diabetes].
Hürter P; Kühnau J
Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):250-2. PubMed ID: 5535600
[No Abstract] [Full Text] [Related]
14. [Medium-term results of treatment with biosynthetic human insulin in diabetic children already in therapy with insulin of animal origin].
Vanelli M; Bolondi O; Boselli E; Chiari G; Vittorangeli R; Rasori E; Nori G; Bernasconi S
Minerva Pediatr; 1987 Aug; 39(15-16):669-74. PubMed ID: 3312993
[No Abstract] [Full Text] [Related]
15. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
[No Abstract] [Full Text] [Related]
16. Lipoatrophy secondary to human insulin treatment. Immunological study.
Igea JM; Escalada J; Cuevas M; Sainz T; Barrio R
Allergol Immunopathol (Madr); 1992; 20(4):173-5. PubMed ID: 1485599
[No Abstract] [Full Text] [Related]
17. Insulin resistance: pathophysiology, diagnosis, and therapeutic implications.
Grunfeld C
Spec Top Endocrinol Metab; 1984; 6():193-240. PubMed ID: 6395415
[No Abstract] [Full Text] [Related]
18. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
Andersen OO
Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
[No Abstract] [Full Text] [Related]
19. [Advantages and drawbacks of human insulin].
Zenobi PD
Schweiz Med Wochenschr; 1991 Apr; 121(14):475-81. PubMed ID: 2035004
[TBL] [Abstract][Full Text] [Related]
20. [Anti-insulin antibodies and insulin resistance].
Wichterle D; Stolba P; Bendlová B; Krnáková A
Vnitr Lek; 1995 Feb; 41(2):146-50. PubMed ID: 7725641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
